SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ciphergen Biosystems(CIPH):
An SI Board Since September 2000
Posts SubjectMarks Bans
510 15 0
Emcee:  mact Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
210Whatever concerns Liotta and Petricoin may have about reproducibility, they are tuck-3/6/2004
209More from Baggerly's group regarding reproducibility: >>Proteomics. 2tuck-2/29/2004
208[Reproducibility of protein profiling update] I'm rereading the literature tuck-2/29/2004
207Device or not, the potential is still being mined. This abstract describes anottuck-2/27/2004
206Correologic -- CIPH's one time partner, now an apparent competitor -- is runtuck-2/25/2004
205The stock is holding up surprisingly well in light of the weak systems and chip tuck-2/17/2004
204[Biomarkers for pancreatic cancer] >>Clin Cancer Res. 2004 Feb 1;10(3):86tuck-2/13/2004
203[Biomarkers for lung cancer] Very good snesitivity and specificity, but I wondetuck-2/9/2004
202[Biomarkers bound to serum carrier proteins -- diagnostic implications] >>tuck-2/9/2004
201Johns Hopkins Researchers Use ProteinChip(R) Technology to Discover Novel Biomarnigel bates-2/6/2004
200Thanks, tuck. From that site: <i>An important new recent development we Biomaven-2/3/2004
199[reproducibility of SELDI experiments] >>Bioinformatics. 2004 Jan 29 [Eputuck-2/3/2004
198Briefing: 10:09 ET CIPH diagnostic test superior -- Pac Growth 10.59 +0.03: Pactom pope-2/3/2004
197Here's something we don't see often. Dr. Rebecca Caffrey, a co-author otuck-2/2/2004
196[New surface chemistry] >>Rapid Commun Mass Spectrom. 2004; 18(2): 157-62tuck-1/28/2004
195Comparison of SELDI with a competing MS technology: >>Rapid Commun Mass Stuck-1/28/2004
194Despite the fact that the error is not from SELDI, it probably means that CIPH ntuck-1/24/2004
193[SELDI for monitoring relapse of nasopharyngeal cancer] >>Clinical Cancertuck-1/21/2004
192[Identification of patients with head and neck cancer using serum protein profiltuck-1/21/2004
191Ciphergen Expands License Agreement with Genencor for Chromatographic Sorbents fnigel bates-1/21/2004
190Ciphergen Names Executive to Head New Clinical Diagnostics Division Monday Januanigel bates-1/12/2004
189Ciphergen Announces Issuance of Patent for Protein Pattern Recognition Combined nigel bates-1/7/2004
188And with respect to the "direct competition," we know that Zyomyx launtuck-1/5/2004
187>>FREMONT, Calif., Jan. 2 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, tuck-1/4/2004
186Can't say I am surprised by the warning. It may be that CIPH's businesstuck-1/3/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News